chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus, Skin discolouration
Clinical narrative: The patient's past medical history included Hypertension since an unknown date. Concomitant products included VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced SKIN DISCOLOURATION (she noticed two pink circles in the under arm around a circle flat and itchy) and PRURITUS (she noticed two pink circles in the under arm around a circle flat and itchy). On 21-Feb-2021, the patient experienced INJECTION SITE RASH (rash around the injection site, which she felt). At the time of the report, SKIN DISCOLOURATION (she noticed two pink circles in the under arm around a circle flat and itchy), PRURITUS (she noticed two pink circles in the under arm around a circle flat and itchy) and INJECTION SITE RASH (rash around the injection site, which she felt) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 22-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (she noticed two pink circles in the under arm around a circle flat and itchy), PRURITUS (she noticed two pink circles in the under arm around a circle flat and itchy) and INJECTION SITE RASH (rash around the injection site, which she felt) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006m20k) for COVID-19 vaccination.     The patient's past medical history included Hypertension since an unknown date. Concomitant products included VITAMINS NOS for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced SKIN DISCOLOURATION (she noticed two pink circles in the under arm around a circle flat and itchy) and PRURITUS (she noticed two pink circles in the under arm around a circle flat and itchy). On 21-Feb-2021, the patient experienced INJECTION SITE RASH (rash around the injection site, which she felt). At the time of the report, SKIN DISCOLOURATION (she noticed two pink circles in the under arm around a circle flat and itchy), PRURITUS (she noticed two pink circles in the under arm around a circle flat and itchy) and INJECTION SITE RASH (rash around the injection site, which she felt) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant Concomitant medications were reported.   No Treatment information for the event was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza, Pain
Clinical narrative: Within 3 hours of shot I had achy body like flu symptoms; Within 3 hours of shot I had achy body like flu symptoms; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included AMLODIPINE and TIMOLOL for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms). At the time of the report, PAIN (Within 3 hours of shot I had achy body like flu symptoms) and INFLUENZA (Within 3 hours of shot I had achy body like flu symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.     No treatment information was provided.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Injection site warmth, Pyrexia, Vaccination site pain, Vaccination site rash
Clinical narrative: \    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore). On 20-Feb-2021, the patient experienced INJECTION SITE WARMTH (hot arm), PYREXIA (fever of 99.7 degrees) and VACCINATION SITE RASH (rash on arm where shot was given about 3x5 inches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Vaccination site pain, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (hot arm), PYREXIA (fever of 99.7 degrees), VACCINATION SITE PAIN (sore) and VACCINATION SITE RASH (rash on arm where shot was given about 3x5 inches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: (High) 99.7 DEGREES.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: updated events outcome as recovered/resolved This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021. The most recent information was received on 27-Apr-2021 and was forwarded to Moderna on 27-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (hot arm), PYREXIA (fever of 99.7 degrees), VACCINATION SITE PAIN (sore) and VACCINATION SITE RASH (rash on arm where shot was given about 3x5 inches) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE PAIN (sore). On 20-Feb-2021, the patient experienced INJECTION SITE WARMTH (hot arm), PYREXIA (fever of 99.7 degrees) and VACCINATION SITE RASH (rash on arm where shot was given about 3x5 inches). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) for Vaccination site pain, at an unspecified dose and frequency. At the time of the report, INJECTION SITE WARMTH (hot arm), PYREXIA (fever of 99.7 degrees), VACCINATION SITE PAIN (sore) and VACCINATION SITE RASH (rash on arm where shot was given about 3x5 inches) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: (High) 99.7 DEGREES.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 27-Apr-2021: updated events outcome as recovered/resolved
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Joint swelling, Paraesthesia, Pyrexia
Clinical narrative: Joint swelling in Fingers and in ankles; Tingling Sensation; Fever - Temperature of 100.4F; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of JOINT SWELLING (Joint swelling in Fingers and in ankles), PARAESTHESIA (Tingling Sensation) and PYREXIA (Fever - Temperature of 100.4F) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced JOINT SWELLING (Joint swelling in Fingers and in ankles), PARAESTHESIA (Tingling Sensation) and PYREXIA (Fever - Temperature of 100.4F). The patient was treated with NAPROXEN SODIUM (ALEVE) for Symptomatic treatment, at an unspecified dose and frequency. On 04-Feb-2021, JOINT SWELLING (Joint swelling in Fingers and in ankles), PARAESTHESIA (Tingling Sensation) and PYREXIA (Fever - Temperature of 100.4F) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 100.4 (High) fever 100.4F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was Not applicable.  Concomitant medication also included Anti-inflammatory to alleviate symptoms.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Injection site is swollen; Injection site is red; Hurt initially, Injection site is very painful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Injection site is swollen), VACCINATION SITE PAIN (Hurt initially, Injection site is very painful) and VACCINATION SITE ERYTHEMA (Injection site is red) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021 at 11:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE PAIN (Hurt initially, Injection site is very painful). On 28-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Injection site is swollen) and VACCINATION SITE ERYTHEMA (Injection site is red). At the time of the report, VACCINATION SITE SWELLING (Injection site is swollen), VACCINATION SITE PAIN (Hurt initially, Injection site is very painful) and VACCINATION SITE ERYTHEMA (Injection site is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment medications were reported.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Limb mass
Clinical narrative: my arm has a big lump; feels a little bit warm; This spontaneous case was reported by a consumer and describes the occurrence of LIMB MASS (my arm has a big lump) and FEELING HOT (feels a little bit warm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced LIMB MASS (my arm has a big lump) and FEELING HOT (feels a little bit warm). At the time of the report, LIMB MASS (my arm has a big lump) and FEELING HOT (feels a little bit warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19 diagnosis; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 diagnosis) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced COVID-19 (COVID-19 diagnosis). At the time of the report, COVID-19 (COVID-19 diagnosis) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Jan-2021, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided. No relevant concomitant medications reported.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rash that is 10 by 15 centimeters; Itching; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (rash that is 10 by 15 centimeters) and PRURITUS (Itching) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 070L20A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL, GLIPIZIDE, PRAVASTATIN, GABAPENTIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and MULTI VITAMIN & MINERAL for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced RASH (rash that is 10 by 15 centimeters) and PRURITUS (Itching). On 13-Feb-2021, RASH (rash that is 10 by 15 centimeters) and PRURITUS (Itching) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment details included topical Benadryl cream.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Nausea, Rash, Vomiting
Clinical narrative: Nausea; Vomiting; Diarrhea; Rash; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea), VOMITING (Vomiting), DIARRHOEA (Diarrhea) and RASH (Rash) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (Nausea), VOMITING (Vomiting), DIARRHOEA (Diarrhea) and RASH (Rash). At the time of the report, NAUSEA (Nausea), VOMITING (Vomiting), DIARRHOEA (Diarrhea) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity, Pyrexia
Clinical narrative: arm  hurt; Tiredness; headache; fever; little nausea; had some tenderness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever) and NAUSEA (little nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever), NAUSEA (little nausea), VACCINATION SITE PAIN (had some tenderness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever), NAUSEA (little nausea), VACCINATION SITE PAIN (had some tenderness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-015789 (Patient Link).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site swelling
Clinical narrative: arm  hurt; Tiredness; headache; fever; little nausea; had some tenderness at the injection site; swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever) and NAUSEA (little nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever), NAUSEA (little nausea), VACCINATION SITE PAIN (had some tenderness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, PAIN IN EXTREMITY (arm  hurt), FATIGUE (Tiredness), HEADACHE (headache), PYREXIA (fever), NAUSEA (little nausea), VACCINATION SITE PAIN (had some tenderness at the injection site) and VACCINATION SITE SWELLING (swelling at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  Treatment information was not provided.   This case was linked to MOD-2021-015789 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling
Clinical narrative: Body aches; Swelling; pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Body aches), SWELLING (Swelling) and PAIN (pain) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029V20A or 029K20A and 025J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Feb-2021, the patient experienced SWELLING (Swelling) and PAIN (pain). On 04-Feb-2021, the patient experienced PAIN (Body aches). At the time of the report, PAIN (Body aches), SWELLING (Swelling) and PAIN (pain) outcome was unknown.            Treatment included antibiotics and anti-inflammatory after 1st dose . Benadryl and ibuprofen after 2nd dose.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pruritus
Clinical narrative: a rash on her upper arm; itchiness that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination.     No Medical History Information was reported.  The patient's past medical history included Thyroid disorder since an unknown date.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of Cream and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included an unknown pill for a thyroid disorder daily. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Feb-2021 and was forwarded to Moderna on 23-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029l20a) for COVID-19 vaccination.     No Medical History Information was reported.  The patient's past medical history included Thyroid disorder since an unknown date.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes). The patient was treated with HYDROCORTISONE for Adverse event, at a dose of Cream and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency. At the time of the report, INJECTION SITE RASH (a rash on her upper arm) and PRURITUS (itchiness that comes and goes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included an unknown pill for a thyroid disorder daily.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash macular, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Fairly large red spot - 5 inch rectangular area in upper left arm; Ring around red spot - left arm, rim around it and the inside part is fading; Itching at the vaccination site - left arm; Bit of pain at the vaccination site; Redness at the vaccination site - left arm, fairly large red spot 5 inch rectangular area in upper left arm, ring around red spot; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Fairly large red spot - 5 inch rectangular area in upper left arm), RASH (Ring around red spot - left arm, rim around it and the inside part is fading), VACCINATION SITE PRURITUS (Itching at the vaccination site - left arm), VACCINATION SITE PAIN (Bit of pain at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site - left arm, fairly large red spot 5 inch rectangular area in upper left arm, ring around red spot) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH MACULAR (Fairly large red spot - 5 inch rectangular area in upper left arm), RASH (Ring around red spot - left arm, rim around it and the inside part is fading), VACCINATION SITE PRURITUS (Itching at the vaccination site - left arm), VACCINATION SITE PAIN (Bit of pain at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site - left arm, fairly large red spot 5 inch rectangular area in upper left arm, ring around red spot). At the time of the report, RASH MACULAR (Fairly large red spot - 5 inch rectangular area in upper left arm), RASH (Ring around red spot - left arm, rim around it and the inside part is fading), VACCINATION SITE PRURITUS (Itching at the vaccination site - left arm), VACCINATION SITE PAIN (Bit of pain at the vaccination site) and VACCINATION SITE ERYTHEMA (Redness at the vaccination site - left arm, fairly large red spot 5 inch rectangular area in upper left arm, ring around red spot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Balance disorder, Chills, Fatigue, Feeling abnormal
Clinical narrative: balance is off; brain fog; breath is not as deep; doesn't feel like himself; A low-grade fever; Felt nauseated; when went to go to sleep, couldn't relax; Sweat a lot; Weak; Progressively began to feel tired; Hard chills and he needed six blankets to keep himself warm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak) and BALANCE DISORDER (balance is off) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and CHILLS (Hard chills and he needed six blankets to keep himself warm). On 26-Jan-2021, the patient experienced SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), FATIGUE (Progressively began to feel tired) and NAUSEA (Felt nauseated). On 27-Jan-2021, the patient experienced PYREXIA (A low-grade fever). On an unknown date, the patient experienced BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep) and FEELING ABNORMAL (doesn't feel like himself). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep), FEELING ABNORMAL (doesn't feel like himself), FATIGUE (Progressively began to feel tired), CHILLS (Hard chills and he needed six blankets to keep himself warm), PYREXIA (A low-grade fever) and NAUSEA (Felt nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Unspecified blood pressure medication, Unspecified  cholesterol medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-083734 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: significant follow up , events were added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083734:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperhidrosis, Hypopnoea, Nausea, Pain in extremity, Pyrexia
Clinical narrative: balance is off; brain fog; breath is not as deep; doesn't feel like himself; A low-grade fever; Felt nauseated; when went to go to sleep, couldn't relax; Sweat a lot; Weak; Progressively began to feel tired; Hard chills and he needed six blankets to keep himself warm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak) and BALANCE DISORDER (balance is off) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and CHILLS (Hard chills and he needed six blankets to keep himself warm). On 26-Jan-2021, the patient experienced SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), FATIGUE (Progressively began to feel tired) and NAUSEA (Felt nauseated). On 27-Jan-2021, the patient experienced PYREXIA (A low-grade fever). On an unknown date, the patient experienced BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep) and FEELING ABNORMAL (doesn't feel like himself). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep), FEELING ABNORMAL (doesn't feel like himself), FATIGUE (Progressively began to feel tired), CHILLS (Hard chills and he needed six blankets to keep himself warm), PYREXIA (A low-grade fever) and NAUSEA (Felt nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Unspecified blood pressure medication, Unspecified  cholesterol medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-083734 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: significant follow up , events were added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083734:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: balance is off; brain fog; breath is not as deep; doesn't feel like himself; A low-grade fever; Felt nauseated; when went to go to sleep, couldn't relax; Sweat a lot; Weak; Progressively began to feel tired; Hard chills and he needed six blankets to keep himself warm; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak) and BALANCE DISORDER (balance is off) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore) and CHILLS (Hard chills and he needed six blankets to keep himself warm). On 26-Jan-2021, the patient experienced SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), FATIGUE (Progressively began to feel tired) and NAUSEA (Felt nauseated). On 27-Jan-2021, the patient experienced PYREXIA (A low-grade fever). On an unknown date, the patient experienced BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep) and FEELING ABNORMAL (doesn't feel like himself). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm was sore), SLEEP DISORDER (when went to go to sleep, couldn't relax), HYPERHIDROSIS (Sweat a lot), ASTHENIA (Weak), BALANCE DISORDER (balance is off), FEELING ABNORMAL (brain fog), HYPOPNOEA (breath is not as deep), FEELING ABNORMAL (doesn't feel like himself), FATIGUE (Progressively began to feel tired), CHILLS (Hard chills and he needed six blankets to keep himself warm), PYREXIA (A low-grade fever) and NAUSEA (Felt nauseated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include Unspecified blood pressure medication, Unspecified  cholesterol medication.   This case was linked to US-MODERNATX, INC.-MOD-2021-083734 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: significant follow up , events were added; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083734:
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain
Clinical narrative: Severe Chills; Felt tired; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Soreness), CHILLS (Severe Chills) and FATIGUE (Felt tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Feb-2021, the patient experienced INJECTION SITE PAIN (Soreness). On 21-Feb-2021, the patient experienced CHILLS (Severe Chills) and FATIGUE (Felt tired). At the time of the report, INJECTION SITE PAIN (Soreness), CHILLS (Severe Chills) and FATIGUE (Felt tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. Treatment included Advil.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Pruritus, Swelling
Clinical narrative: Swelling; itching; hard to touch; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swelling), PRURITUS (itching) and INDURATION (hard to touch) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced SWELLING (Swelling), PRURITUS (itching) and INDURATION (hard to touch). At the time of the report, SWELLING (Swelling), PRURITUS (itching) and INDURATION (hard to touch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Pregnancy
Clinical narrative: Pregnant; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 27-Oct-2021. On an unknown date, the patient experienced PREGNANCY (Pregnant). At the time of the report, PREGNANCY (Pregnant) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 32year-old female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, COVID-19
Clinical narrative: Tested positive to covid; Loss of taste; Loss of smell; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history).    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell). At the time of the report, COVID-19 (Tested positive to covid), AGEUSIA (Loss of taste) and ANOSMIA (Loss of smell) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Feb-2021, COVID-19: Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Previous Pregnancies). Concurrent medical conditions included Drug allergy (allergic to metaclopramide).   On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 10-Dec-2020 and the estimated date of delivery was 16-Sep-2021. On 23-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  second week of the pregnancy.  On 23-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, Pregnancy test: positive (Positive) positive.         No concomitant medication provided by the reporter.  No treatment information provided by the reporter
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: 24,25,26 Jan2021 caller had the worst side effects symptoms; felt very very tired all week long; 5 or 6 days after receiving the shot: Nausea; arm was very swollen; sore; red around the injection site around 3x3 inches; 5 or 6 days after receiving the shot: headache; 5 or 6 days after receiving the shot: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), HEADACHE (5 or 6 days after receiving the shot: headache) and INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (5 or 6 days after receiving the shot: headache), INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm) and INJECTION SITE ERYTHEMA (red around the injection site around 3x3 inches). On an unknown date, the patient experienced ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), INJECTION SITE SWELLING (arm was very swollen) and PAIN (sore). At the time of the report, ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), HEADACHE (5 or 6 days after receiving the shot: headache), INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm), INJECTION SITE SWELLING (arm was very swollen), INJECTION SITE ERYTHEMA (red around the injection site around 3x3 inches) and PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Nausea, Pain
Clinical narrative: 24,25,26 Jan2021 caller had the worst side effects symptoms; felt very very tired all week long; 5 or 6 days after receiving the shot: Nausea; arm was very swollen; sore; red around the injection site around 3x3 inches; 5 or 6 days after receiving the shot: headache; 5 or 6 days after receiving the shot: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), HEADACHE (5 or 6 days after receiving the shot: headache) and INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced HEADACHE (5 or 6 days after receiving the shot: headache), INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm) and INJECTION SITE ERYTHEMA (red around the injection site around 3x3 inches). On an unknown date, the patient experienced ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), INJECTION SITE SWELLING (arm was very swollen) and PAIN (sore). At the time of the report, ADVERSE DRUG REACTION (24,25,26 Jan2021 caller had the worst side effects symptoms), FATIGUE (felt very very tired all week long), NAUSEA (5 or 6 days after receiving the shot: Nausea), HEADACHE (5 or 6 days after receiving the shot: headache), INJECTION SITE PAIN (5 or 6 days after receiving the shot: sore left arm), INJECTION SITE SWELLING (arm was very swollen), INJECTION SITE ERYTHEMA (red around the injection site around 3x3 inches) and PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Functional gastrointestinal disorder, Nausea, Vomiting
Clinical narrative: severe abdominal pain; nausea; vomiting; bowels have been getting smaller and smaller, and have been really hard to excrete; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea), VOMITING (vomiting) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication.     The patient's past medical history included No adverse event.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea), VOMITING (vomiting) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete). On 20-Feb-2021, VOMITING (vomiting) outcome was unknown. At the time of the report, ABDOMINAL PAIN (severe abdominal pain), NAUSEA (nausea) and FUNCTIONAL GASTROINTESTINAL DISORDER (bowels have been getting smaller and smaller, and have been really hard to excrete) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications reported. Treatment included Tylenol and Tums.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Decreased appetite, Fatigue, Pollakiuria, Pyrexia
Clinical narrative: lost appetite; very thirsty; increase urination; 102 fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lost appetite), THIRST (very thirsty), POLLAKIURIA (increase urination), PYREXIA (102 fever) and FATIGUE (fatigue) in a 93-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Hypercholesteremia.   On 21-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced DECREASED APPETITE (lost appetite), THIRST (very thirsty), POLLAKIURIA (increase urination), PYREXIA (102 fever) and FATIGUE (fatigue). At the time of the report, DECREASED APPETITE (lost appetite), THIRST (very thirsty), POLLAKIURIA (increase urination), PYREXIA (102 fever) and FATIGUE (fatigue) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Body temperature: 102 (Inconclusive) 102 fever.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant medications included unspecified high blood pressure and cholesterol medication.